Abstract:Objective To explore the relationship of advanced glycation end products (AGE) and diabetic skin with microangiopathy and the mechanism of impaired wound healing. Methods 18 male Sprague-Dawley(SD) rats weighing 200～220 g were randomized into the control and STZ-induced diabetic groups. The shaved skin specimens from the back of rats were collected at 12 w after STZ-inducing. Skin AGE concentrations were assessed by detecting the total fluorescence in tissue collagen with F-3010 spectrofluorometer and immunohistochemistry assay. The ultrastructural changes of skin microvessels were observed by electronmicroscopy. Human umbilical vein endothelial cells ECV304 were cultured in vitro with AGE modified human serum albumin (AGE-HSA) at the concentrations of 12.5, 25, 50, and 100 μg/ml for 6, 12, 24, and 48 hours. The cells incubated with HSA of the same concentrations were used as controls. The cell vitality at each time point was analyzed by MTT assay and fluorescence microscopy. Results Skin fluorescence of diabetic rats increased significantly in comparing with age-matched controls thoughout the course of the study (P0.05). Consistent with collagen fluorescence, the positive expression of skin AGE in diabetic animals was much stronger than the weak expression in healthy controls. Furthermore, skin microangiopathy was easily detected in the diabetic group, manifesting as the degenerated vascular endothelial cells and thickening of basement membrane. The absorption of ECV304 cells cultured with AGE-HSA at the concentration of 100 μg/ml for 6 h was significantly lower than that in the control group (P0.01). Meanwhile, flow cytometry and fluorescence microscopy showed higher proportions of apoptotic cells among the ECV304 cells cultured with 100 μg/ml AGE-HSA than those among the control cells at each time point (P0.01). Conclusion AGE is an important cause of diabetic skin microangiopathy. Furthermore, AGE modification-induced pathobiological cascade may be involved in the mechanism of impaired wound healing in diabetes neoangiogenesis impairment or retardation. (Shanghai Med J, 2004,27:532-535)

Pathological changes of retinal Müller cell in diabetic rat in vitro

Change of expression of glutamine synthetase in early diabetic rats' retina

Early Pathological Changes of Retinal Nerve Tissue in Experimental Diabetic Rat

Change of dendrites position in the inner plexi form layer of retinal ganglion cells in the early stage of diabetes

Pathological impairment of microcirculation and abnormal deposition of AGEs on retinae in diabetic ratinopathy of rats

Advanced Glycation End-Products Stimulate Basic Fibroblast Growth Factor Expression in Cultured Müller Cells.

Morphological changes in diabetic rat’s retina induced by streptozotocin

The Morphological Study of Muller Cells with Enzyme Histochemical Staining in Retina of Induced Diabetic Rats

Expression of E-selectin of adhesive molecule in retina of rats with diabetic retinopathy

A light and electron microscopy observation of diabetic retinopathy in rat

Microglial Activation and Ganglion Cells Damages in the Rat Retina with Early Stage Streptozotocin-Induced Diabetes

The mechanism study of retinal nerve cell injury in rats with diabetes mellitus

Effect of high glucose on rat retinal Müller cells cultured in vitro

Effect of superoxide dismutase on apoptosis induced by advanced glycation end products in cultured retinal microvascular pericytes

Establishment of Diabetic Retinopathy Rat Model

Effects of high glucose on ultrastructure of Müller cells and structure and function of retina

Pathophysiological changes of dermal tissue in diabetic rats and their mechanisms

Mechanistic Study of Endogenous Skin Lesions in Diabetic Rats

Exogenous Advanced Glycosylation End Products Induce Diabetes-Like Vascular Dysfunction in Normal Rats: a Factor in Diabetic Retinopathy

Correlative study of advanced glycation end products (AGE) and diabetic skin with microangiopathy

Research on olfactory mechanism of the cutaneous "underlying disorder" in diabetic rats